Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype
- PMID: 28437320
- PMCID: PMC5471130
- DOI: 10.1097/MLR.0000000000000729
Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype
Erratum in
-
Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype: Erratum.Med Care. 2017 Dec;55(12):1062. doi: 10.1097/MLR.0000000000000836. Med Care. 2017. PMID: 29140954 No abstract available.
Abstract
Background: Fried and colleagues described a frailty phenotype measured in the Cardiovascular Health Study (CHS). This phenotype is manifest when ≥3 of the following are present: low grip strength, low energy, slowed waking speed, low physical activity, or unintentional weight loss. We sought to approximate frailty phenotype using only administrative claims data to enable frailty to be assessed without physical performance measures.
Study design: We used the CHS cohort data linked to participants Medicare claims. The reference standard was the frailty phenotype measured at visits 5 and 9. With penalized logistic regression, we developed a parsimonious index for predicting the frailty phenotype using a linear combination of diagnoses, operationalized with claims data. We assessed the predictive validity of frailty index by examining how well it predicted common aging-related outcomes including hospitalization, disability, and death.
Results: There were 4454 CHS participants from 4 clinical sites. In total, 84% were white, 58% were women and their mean age was 72 years at enrollment. Approximately 11% of the cohort was frail. The model had an area under the receiver operating curve of 0.75 to concurrently predict a frailty phenotype. This Claims-based Frailty Indicator significantly predicted death (odds ratio, 1.84), time to death (hazards ratio, 1.71), number of hospital admissions (incidence rate ratio, 1.74), and nursing home admission (odds ratio, 1.47) in models adjusted for age and sex.
Conclusions: Claims data alone can be used to classify individuals as frail and nonfrail. The Claims-based Frailty Indicator might be used in research with large datasets for confounding adjustment or risk prediction. The indicator might also be used for emergency preparedness for identification of regions enriched with frail individuals.
Conflict of interest statement
The authors have no conflicts of interest to report.
Figures
Comment in
-
Comparing Approaches to Measure Frailty in Medicare Data: Deficit-Accumulation Frailty Index Versus Phenotypic Frailty.J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):989-990. doi: 10.1093/gerona/gly054. J Gerontol A Biol Sci Med Sci. 2018. PMID: 29697776 Free PMC article. No abstract available.
References
-
- Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156. - PubMed
-
- Chang SF, Lin PL. Frail phenotype and mortality predication: a systematic review and meta-analysis of prospective cohort studies. Int J Nurs Stud. 2005 Aug;52(8):1362–74. - PubMed
-
- Frisoli A, Jr, Ingham SJ, Paes ÂT, et al. Frailty predictors and outcomes among older patients with cardiovascular disease: Data from Fragicor. Arch Gerontal Geriatr. 2015;61(1):1–7. - PubMed
Publication types
MeSH terms
Grants and funding
- N01 HC085080/HL/NHLBI NIH HHS/United States
- R21 AG048494/AG/NIA NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01 HC085082/HL/NHLBI NIH HHS/United States
- U01 HL130114/HL/NHLBI NIH HHS/United States
- P30 AG021334/AG/NIA NIH HHS/United States
- HHSN268201200036C/HL/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- R01 AG023629/AG/NIA NIH HHS/United States
- N01 HC085081/HL/NHLBI NIH HHS/United States
- HHSN268200800007C/HL/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC085083/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
